American Thyroid Association (ATA) Satellite Symposium – The 2016 Release of Two ATA Clinical Guidelines:

I. Management of Hyperthyroidism

II. Thyroid Illness During Pregnancy

 Thursday, March 31, 2016, 1:00 PM-5:30 PM
Boston, Massachusetts

2016 ATA Guidelines: Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis

Chair: Douglas Ross, MD, Massachusetts General Hospital

Numerous studies since the publication of the 2011 guidelines have addressed the diagnosis and management of thyrotoxic patients. The ATA has developed new and updated evidence-based recommendations to guide the clinical assessment and management of patients with hyperthyroidism and other causes of thyrotoxicosis. Task force members will give special focus to:

  •  New paradigms for establishing the etiology of thyrotoxicosis
  •  Updated evidence for choosing treatment options for hyperthyroidism
  •  Expanded coverage of less common causes of thyrotoxicosis

2016 ATA Guidelines: Thyroid Disease During Pregnancy

Chairs: Elizabeth Pearce, MD, Boston University and Erik Alexander, MD, Brigham and Women’s Hospital

Thyroid disease is common in pregnant women. The diagnosis and treatment of thyroid dysfunction in pregnancy provides unique challenges. A large amount of new information and evidence grading processes has become available since the 2011 guidelines prompting the ATA to develop new and updated evidence-based recommendations to assist in the clinical management of pregnant patients with thyroid disease. Task force members will give special focus to:

  • New definitions and treatment paradigms for hypothyroidism in pregnancy
  •  Treatment of hyperthyroidism in pregnant women
  •  Screening for thyroid dysfunction in pregnancy


To view or purchase available webcast presentations from this meeting, please visit


2016 ATA Satellite Symposium Program Agenda (PDF File, 135 KB)